{
    "N/R/U": null,
    "Applicant": "CELLTRION, Inc.",
    "BLA Number": "761420",
    "Proprietary Name": "Avtozma",
    "Proper Name": "tocilizumab-anoh",
    "BLA Type": "351(k) Interchangeable",
    "Strength": "162MG/0.9ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Pre-Filled Syringe",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "January 24, 2025",
    "Ref. Product Proper Name": "tocilizumab",
    "Ref. Product Proprietary Name": "Actemra",
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "1996",
    "Product Number": "004",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": "Date TBD",
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}